Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS US Court Backs Jury Verdict in Actos Suit, Orders Takeda to Pay US$6 Billion in Punitive Damages
September 5, 2014
-
REGULATORY Industry on Alert as Reformist Shiozaki Tapped as New Health Minister
September 4, 2014
-
REGULATORY Yasuhisa Shiozaki Tapped as New Health Minister
September 3, 2014
-
REGULATORY MOF Official Unami Urges Full-Scale NHI Price Revision upon Next Sales Tax Hike
September 2, 2014
-
BUSINESS Novartis Pharma Submits Improvement Plan, Notifies of Over 2,500 Unreported Serious ADRs
September 1, 2014
-
BUSINESS Sanofi Greater China Head Baschiera to Shepherd Japan Unit
August 29, 2014
-
BUSINESS Roche Obtains First Refusal Right for All Chugai’s Products with Partial Amendment to Strategic Alliance Deal
August 29, 2014
-
REGULATORY Chuikyo Grants Unprecedented 60% Premium to Ono’s Opdivo
August 28, 2014
-
BUSINESS Otsuka Holdings Takes Aim at 915 Billion Yen Pharma Sales in FY2018 after Abilify Patent Loss
August 27, 2014
-
ORGANIZATION CDISC CEO Advises Drug Makers to Collect Data Based on CDASH
August 27, 2014
-
REGULATORY PAFSC Second Committee to Review Nobelpharma’s Anticancer Drug Streptozocin on Sept. 5
August 26, 2014
-
BUSINESS Latuda Goes on Sale in UK: Sumitomo Dainippon
August 25, 2014
-
BUSINESS Pfizer Japan to Create New Unit for its Innovative Drug Business in December
August 22, 2014
-
ACADEMIA Kyoto University, Astellas Aim to Develop Immunological Disease Cures, 11 Target Molecules Now under Screening
August 21, 2014
-
BUSINESS MTPC, AZ Ink Research Collaboration Deal in Diabetic Nephropathy
August 21, 2014
-
BUSINESS Japan to See Grueling Battle for Free-Price Viagra Generics
August 20, 2014
-
BUSINESS Pfizer Reveals First Doctor Payments amid Delays in Disclosure
August 19, 2014
-
BUSINESS Genzyme Japan Appoints Former Bausch & Lomb Japan President Ashikaga as Its New President
August 18, 2014
-
REGULATORY 148 Blopress Generics OKed, Competition with AGs Likely upon December Listing
August 15, 2014
-
REGULATORY PMDA Will Prosper by Promoting Review Work, Research, and Training Together: Chief Executive
August 13, 2014
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…